An organised and economic approach in France of the ambulatory treatment of febrile neutropenia;Approche organisationnelle et économique en France du traitement ambulatoire des neutropénies fébriles

Presse Medicale

Volumn 33, Issue 5, 2004, Pages 338-342

  Turlure, P ^a   Durand Zaleski, Isabelle ^b  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b Service Evaluation des Pratiques   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; COMORBIDITY; ECONOMIC ASPECT; FEBRILE NEUTROPENIA; FRANCE; HEALTH CARE COST; HEALTH CARE QUALITY; HOME CARE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFECTION; MORBIDITY; NURSE; OUTPATIENT CARE; PATIENT CARE; PATIENT COMPLIANCE; PHYSICIAN; REVIEW; SAFETY; TREATMENT INDICATION;

EID: 1542406075     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(04)98580-6     Document Type: Short Survey

References (21)

1. Takott JA, Whalen A, Clark J, Rieker PP, Findberg R. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 1994; 12: 107-14.
2. Talcott JA, Finberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Clinical Identification of a low-risk subgroup at presentation. Arch Intern Med 1988; 148: 2561-8.
3. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two center validation of a predictive rule. J Clin Oncol 1992; 10: 316-22.
4. Buchanan GR. Approach to treatment of the febrile cancer patient with low-risk neutropenia. Hematol Oncol Clin North Am 1993; 7: 919-35
5. Uzun O, Anaissie EJ. Outpatient therapy for febrile neutropenia who, when, and how? J Antimicrob chemother 1999; 43: 317-20.
6. Rolston KV. New trends in patient management: risk-based therapy for febrile patients with neutropenia. Clin infect dis 1999; 29: 515-21.
7. Gardembas-Pain M, Desablens B, Sensebe L, Lamy T, Gandhour C, Boasson M. Home treatment of febrile neutropenia: an empirical oral antibiotic regimen. Ann Oncol 1991; 2: 485-7.
8. Malik IA, Khan WA, Aziz Z, Karim M. Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with nonhematologic neoplasms. Clin Infect Dis 1994; 19: 522-7.
9. Malik IA, Khan WA, Karim M, Aziz Z, Khan MA. Feasability of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomised trial. Am J Med 1995; 98: 224-31.
10. Rubinstein EB, Rolston KV, Benjamin RS et al. Out patient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 1993; 71: 3640-6.
11. Mullen CA, Petropoulos D, Roberts WM et al. Out patient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer 1999; 86: 126-34.
12. Hidalgo M, Hornedo J, Lumbreras C et al. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever. Cancer 1999; 85: 213-19.
13. Aquino VM, Herrera L, Sandler ES, Buchanan GR. Feasability of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 2000; 88: 1710-14.
14. Aquino VM, Tkaczewski I, Buchanan GR. Early discharge of low-risk febrile neutropenic children and adolescents with cancer. Clin Infect Dis 1997; 25: 74-8.
15. Paganini HR, Sarkis CM, De Martino MG et al. Oral administration of cefixime to lower risk febrile neutropenic children with cancer. Cancer 2000; 88: 2848-52.
16. Paganini HR, Rodriguez-Brieshcke T, Zubizarreta P et al. Oral ciprofloxacin in the management of children with cancer lower risk febrile neutropenia. Cancer 2001; 91: 1563-7.
17. Lucas KG, Brown AE, Armstrong D, Chapman D, Heller G. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 1996; 77: 791-8.
18. Shenep JL, Flynn PM, Baker OK et al. Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer. Clin Infect Dis 2001; 32: 36-43.
19. Karthaus M, Egerer G, Kullmann KH, Ritter J, Jürgens H. Ceftriaxone in outpatient treatment of cancer patients with fever and neutropenia. Eur J Clin Microbiol Infect Dis 1998; 17: 501-4.
20. Petrilli AS, Dantas LS, Campos MC, Tanaka C, Ginani VC, Seber A. Oral ciprofloxacin vs intravenous ceftriaxone administered in an out-patient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. Med Pediatr Oncol 2000; 34: 87-91.
21. Bash RO, Katz JA, Cash N, Buchanan GR. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia. Cancer 1994; 74: 189-96.